Luis H. Pagán Rivera is a Ph.D. candidate at the University of Puerto Rico Medical Sciences Campus Physiology Department, and a faculty member at Ana G. Méndez University in the Department of Science and Technology. His research focuses on the intersection of spinal cord injury (SCI), the gut microbiome, and neuroinflammation. Specifically, he investigates how therapeutic interventions—such as antibiotics and selective estrogen receptor modulators like tamoxifen—modulate gut microbial communities and influence recovery following SCI. His work aims to uncover novel gut-brain axis mechanisms that can promote neuroprotection and functional restoration after SCI. With a background in molecular microbiology, he integrates microbiome profiling, behavioral testing, and statistical modeling to explore host-microbe interactions in preclinical models of injury and disease.
Luis H. Pagán Rivera is a Ph.D. candidate at the University of Puerto Rico Medical Sciences Campus Physiology Department, and a faculty member at Ana G. Méndez University in the Department of Science and Technology. His research focuses on the intersection of spinal cord injury (SCI), the gut microbiome, and neuroinflammation. Specifically, he investigates how therapeutic interventions—such as antibiotics and selective estrogen receptor modulators like tamoxifen—modulate gut microbial communities and influence recovery following SCI. His work aims to uncover novel gut-brain axis mechanisms that can promote neuroprotection and functional restoration after SCI. With a background in molecular microbiology, he integrates microbiome profiling, behavioral testing, and statistical modeling to explore host-microbe interactions in preclinical models of injury and disease.